Kangstem Biotech, a stem cell therapy provider, plans to develop the world's first stem cell treatment that fundamentally treats atopic dermatitis with a single dose."We received approval for new phase 3 clinical trials for FureStem AD from the Ministry of Food and Drug Safety in May and will start
Bayer’s Xarelto (ingredient: rivaroxaban) has reduced the risk of death of non-valvular atrial fibrillation (NVAF) patients with type 2 diabetes by about 10 percent, as well as their hospitalization caused by bleeding, compared with Warfarin.The company conducted studies from November 2011 to Decemb
Raon Pharma said it would sell the “cheapest hair loss treatment,” heating up price competition in the hair loss prescription drug market.On Monday, Raon Pharma said it would roll out Finaon Tab. 1mg (finasteride). The announcement came 10 months after the launch of Finawin Tab. 1mg (finasteride). B
Janssen Korea said Monday that Cherry Huang has been appointed as its new chief executive officer effective June 1.Huang will double as Janssen's North Asian head by managing its branches in Taiwan and Hong Kong, it said.New CEO Huang, who joined Janssen in 1998, has held various positions in Jansse
Cheong Wa Dae and the ruling Democratic Party of Korea have praised Samsung Biologics' deal with Moderna to manufacture the latter's mRNA Covid-19 in Korea as a huge success.However, experts showed more cautious reactions to the deal and other vaccine-related agreements.Some industry officials and h
Novo Nordisk said Monday that its type-2 diabetes treatment Xultophy has shown superior efficacy in reducing Hemoglobin A1c (HbA1c) level, weight change, and the hypoglycemia events with a lower dose in phase 3 clinical trials.Kangbuk Samsung Hospital Professor Lee Eun-jeong and Seoul National Unive
Daewoong Pharmaceutical said that the U.S. Food and Drug Administration has granted orphan drug designation (ODD) for DWN12088 that treats systemic scleroderma.The designation comes after the drug won an ODD status to treat idiopathic pulmonary fibrosis (IPF) in August 2019.Systemic scleroderma is a
Institut Pasteur Korea (IPK) said Friday that it has agreed to team up with Institut Pasteur to form a global research unit, Ai3D, for image-based profiling of new drug discovery and development using artificial intelligence.The international research team aims to develop next-generation new drug te
The greater Seoul area has been experiencing a shortage of Tylenol since the health authorities announced that people should take Tylenol (ingredient: acetaminophen) when they have a fever after receiving the Covid-19 vaccine."It seems okay to take fever reducers such as Tylenol if you start develop
Pfizer Korea said that it has confirmed improved efficacy and safety of Vizimpro, its epidermal growth factor receptor (EGFR) mutation treatment for non-small cell lung cancer (NSCLC), on Asian patients, including Koreans.The company conducted a subgroup analysis of its ARCHER 1050 phase 3 clinical
MSD’s antidiabetic drug Steglatro (ingredient: ertugliflozin), a sodium-glucose cotransporter 2 (SGLT-2) inhibitor, demonstrated clinical benefits in renal functions, a study said.The results enhance evidence that SGLT-2 inhibitors could be beneficial in kidney disease.An exploratory analysis of the
International Vaccine Institute (IVI) Director-General Jerome Kim said Wednesday that Korea could be a hub for making Covid-19 vaccines in Asia.Kim said that Korean biopharmaceutical companies have the capability to begin manufacturing Covid-19 vaccines within nine months, pointing out that the glob
Pirfenidone, a treatment for idiopathic pulmonary fibrosis with its original drug’s patent expired, showed a remarkable therapeutic effect in heart failure with preserved ejection fraction (HFpEF), a study showed.The study drew much attention because researchers have failed to develop an HFpEF treat
LSK Global PS said it has released an infographic showing the current situation of Korea’s contract research organization (CRO) market and reliable criteria for selecting CROs to celebrate the World Clinical Trials Day on Thursday.According to the company, there are 65 CROs in Korea conducting contr
Takeda Pharmaceuticals Korea launched a new oncology business unit in 2019, following the global headquarters’ policy to focus on four core treatment areas – oncology, gastroenterology, neuroscience, and rare diseases.However, the outlook for the oncology business dimmed when the Covid-19 pandemic h
Yuyu Pharmaceutical said Tuesday that it has launched two ethical drugs (ETC) for treating dyslipidemia -- Newmacor R Soft Cap. and Yutozet Tab.Newmacor is a combination treatment that combines rosuvastatin and omega-3 acid ethyl ester 90 and treats LDL-C (low-density lipoprotein cholesterol) and ty
Hanmi Pharmaceutical said it would manufacture Genexine's Covid-19 prevention DNA vaccine under development, GX-19N, on a consignment basis.Hanmi and Genexine signed a contract to develop the GX-19N production process and product manufacturing worth 24.5 billion won ($21.6 million) and form a partne
SK Bioscience said that it has obtained an international certification that recognizes excellence for its vaccine production capabilities.The company’s production facility and process and quality systems to manufacture the Covid-19 jabs at its vaccine plant in Andong, North Gyeongsang Province, have
Celltrion said it attained robust growth in sales and profits in the first6 quarter due to its expanding market share of flagship biosimilar drugs.The development of its Covid-19 antibody therapy development is also nearing an end, the company added.Celltrion recorded sales of 457 billion won ($450
Daewoong Pharmaceutical said Friday that it has confirmed the safety and efficacy of the repeated, long-term administration of its botulinum toxin (BTX) product, Nabota, or Jeuveau as called in the U.S., in the follow-up of phase 2 trials conducted in America, Canada, and Europe.Some 94.1 percent of